Fire1 Fire1 Fire1

Fire1

Monitoring device used in case of risk of heart failure

The Foundry Innovation and Research 1, Ltd. (FIRE1), was founded in 2013 and is the first European spinout of The Foundry, a highly successful medical device incubator from Menlo Park, California. The company, located in Ireland, focuses on developing a novel remote monitoring device to improve outcomes for patients suffering from an increased risk of heart failure. Early detection enables a timely intervention and adjustment of pharmacotherapy, thus avoiding hospitalisation, improving quality of life and lowering healthcare costs.

Life Sciences

Visit website

Investment  details

Entry

2018

Staff

Location

Ireland

Partnership Gimv Partnership Gimv Partnership Gimv

Partnership Gimv

Gimv's decision to partner with FIRE1 is driven by the immense potential in a rapidly expanding market, characterised by increasingly unmet needs, particularly in the context of cardiac disease – a leading global cause of mortality. The financial support extended to FIRE1 is empowering the company to continue the development and enhancement of their innovative remote monitoring solution. This technology is poised to make significant strides in improving the overall outcomes and quality of life for individuals suffering from heart failure.